Clinicopathological features of gastric carcinomas with NTRK-rearrangement/amplification: report of four cases.
10.3760/cma.j.cn112151-20221008-00840
- Author:
An Di XU
1
;
Yao FU
1
;
Xiao Hong PU
1
;
Hong Yan WU
1
;
Qi SUN
1
;
Xiang Shan FAN
1
Author Information
1. Department of Pathology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Male;
Female;
Receptor, trkA/genetics*;
Stomach Neoplasms/surgery*;
In Situ Hybridization, Fluorescence;
Biomarkers, Tumor/genetics*;
Translocation, Genetic;
Carcinoma;
Oncogene Proteins, Fusion/genetics*;
Chromosomal Proteins, Non-Histone/genetics*
- From:
Chinese Journal of Pathology
2023;52(5):454-459
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the clinicopathological, immunohistochemical and molecular genetic characteristics of gastric carcinoma with NTRK-rearrangement/amplification. Methods: The clinicopathological data of gastric carcinoma cases with NTRK-rearrangement/amplification diagnosed from January 2011 to September 2020 at the Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, China, were collected. The clinicopathological, immunophenotypic and molecular pathological features were analyzed. The relevant literature was reviewed. Results: There were 4 cases of gastric carcinoma with NTRK-rearrangement/amplification. All 4 patients were male, aged 57-67 years (average, 63 years). Tumor sizes ranged from 3.5 to 5.2 cm (average, 4.8 cm). All tumors were in the antrum. All 4 patients underwent radical gastrectomy and were followed up after the surgery. Morphologically, all tumors showed histological features with enteroblastic-differentiated gastric carcinoma. Tumor cells showed predominantly tubular/papillary architecture, with conspicuous vesicular nuclei and pale staining or transparent cytoplasm. Immunohistochemistry showed pan-TRK expression in all cases, with various degrees of positivity in the cytoplasm. All cases were subject to NTRK1/2/3 detection using fluorescence in situ hybridization. There were NTRK translocations in 2 cases and NTRK amplifications in 2 cases. These cases were further verified by RNAseq next generation sequencing which confirmed that NTRK1 gene translocation (TPM3-NTRK1) and NTRK2 gene translocation (NTRK2-SMCHD1) occurred in two cases, respectively. Conclusions: NTRK mutation occurs less frequently in gastric cancer. In this study, the cases mainly occur in the antrum. The morphology has the characteristics of enteroblastic differentiation. The tumors have unique histological, immunophenotypic and molecular characteristics, which require much attention from pathologists to effectively guide clinicians to choose the best treatment.
